(Philadelphia,
PA) - Dr. Michael Ming has been appointed an
Assistant Professor in the Department of Dermatology
at the University of Pennsylvania School of Medicine.
After earning his medical degree in 1993 from Harvard
Medical School, Dr. Ming completed an internship at
Massachusetts General Hospital in Boston, MA, a residency
at Harvard Medical School and fellowships at the University
of California in San Francisco, CA, and the Veteran
Affairs Medical Center in San Francisco.
From 1999 to 2000, Dr. Ming served as Clinical Instructor
in Pathology at the University of California, and from
2000 to 2002 as Instructor of Dermatology at the University
of Pennsylvania School of Medicine.
Dr. Ming's research interests are risk factors related
to melanoma and dysplastic moles, and analyzing the
microscopic misdiagnosis of melanoma. He is currently
developing models for predicting the occurrence of second
primary melanomas and working to identify the characteristics
associated with microscopic misdiagnosis of melanoma.
Dr. Ming is also assessing the attitudes and beliefs
of dermatologists and dermapathologists on the relationship
between dysplastic moles and melanoma. .
In 2000, Dr. Ming received the Award for Young Investigators
in Dermatology from the American Academy of Dermatology.
Dr. Ming has co-authored original research studies
and abstracts in peer-reviewed journals and written
or co-written editorials, reviews and chapters for print
publications.
Dr. Ming holds memberships in a number of national
professional societies, including the American Academy
of Dermatology, the American Medical Association, and
the Massachusetts Medical Society.
# # #
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.